AbbVie Inc.
AbbVie Inc. logo
ABBV

AbbVie Inc. (ABBV)

$163.661.26%

Market is closed
– opens on 8 PM, 05 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$160.58
Day's Range
$163.755
$112.61
52-Week Range
$171.07
1 month return12.65%
3 month return18.95%
1 year return34.87%
5 year return71.88%

Company Information

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. The Company strives to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.
OrganizationAbbVie Inc.
Employees50000
CEOMr. Richard A. Gonzalez
IndustryHealth Technology

Analyst Recommendation

based on 24 analysts ratings

Buy
75%
Buy
20%
Hold
4%
Sell

Based on 24 Wall street analysts offering stock ratings for AbbVie Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Downside of 2.58%

Current

$163.66

Target

$159.44

Recommendation Trend

Based on 24 analyst

Current1M Ago3M Ago
Buy
18
21
22
Hold
5
9
8
Sell
1
1
1
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
285.8B
Book Value
$9.04
Dividend Share
5.64
Dividend Yield
3.6999999999999997%
Earnings Per Share (EPS)
7.5
PE Ratio
21.55
PEG Ratio
1.28
Wall Street Target Price
159.44

Valuation

Trailing PE21.55
Forward PE13.93
Price/Book (mrq)
17.65
Enterprise Value
340.0B
Enterprise Value/Revenue
5.88
Enterprise Value/Ebitda
20.08

Technicals

Beta
0.66
50 Day MA
147.3
200 Day MA
148.9

Sustainability

Rating Date2019-01-01
Total Esg
34.86
Total Esg Percentile
65.78
Environment Score4.96
Environment Score Percentile7.0
Social Score22.65
Social Score Percentile7.0
Governance Score16.25
GovernanceScorePercentile7.0
Controversy Level3.0

Institutional Holdings

Vanguard Group Inc

8.82%

State Street Corporation

4.38%

JPMorgan Chase & Co

3.17%

Capital Research & Mgmt Co - Division 3

2.59%

Capital Research Global Investors

2.05%

T. Rowe Price Associates, Inc.

1.74%

Discover more

Frequently Asked Questions

What is AbbVie Inc. share price today?

Can Indians buy AbbVie Inc. shares?

How can I buy AbbVie Inc. shares from India?

Can Fractional shares of AbbVie Inc. be purchased?

What are the documents required to start investing in AbbVie Inc. stocks?

What are today’s High and Low prices of AbbVie Inc.?

What are today’s traded volumes of AbbVie Inc.?

What is today’s market capitalisation of AbbVie Inc.?

What is the 52 Week High and Low Range of AbbVie Inc.?

How much percentage AbbVie Inc. is down from its 52 Week High?

How much percentage AbbVie Inc. is up from its 52 Week low?

What are the historical returns of AbbVie Inc.?

Who is the Chief Executive Officer (CEO) of AbbVie Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*